SEC Form 4 · accession 0001144204-15-023950
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rene Pierre Azria
Director
Period of report
Apr 17, 2015
Accepted (ET)
Apr 21, 2015 · 8:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.98 | Apr 17, 2015 | A | 50,000 | A | — | Apr 17, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The stock options shall vest quarterly over a three-year period, with 1/12 of the stock options granted vesting quarterly commencing on July 17, 2015.